PTC Therapeutics, Inc. (PTCT)

NASDAQ

$60.79

$-2.22

(-3.53%)

Regular Market

PTC Therapeutics, Inc. (PTCT) Live Price Chart

Last updated: ⁦2026-10-13 15:20:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

PTC Therapeutics, Inc. (PTCT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $60.79, with a market capitalisation of $5.40B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $60.61 to $90.87. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.40B
Open	$62.64
Day's High	$90.87
Day's Low	$4.03
Previous Close	$62.92
Volume	106.79K
Average Volume	1.13M
P/E Ratio	--
52-Week High	$90.87
52-Week Low	$60.61
Dividend Yield	--
Earnings Date	--

PTC Therapeutics, Inc. (PTCT) Stock Price Today

PTC Therapeutics, Inc. (PTCT) is currently trading at $60.79 as of 2026-10-13 15:04:53, down 3.39% ($2.14) from the previous close of $62.92

During today's regular trading session, PTCT has traded between $4.03 and $90.87, with a trading volume of 106.79K shares. The current price is near the upper end of today's range.

PTC Therapeutics, Inc. (PTCT) 7-Day Stock Price Change

Over the past seven days, PTC Therapeutics, Inc. (PTCT) moved from $63.46 to $60.79, representing a decline of 4.22% ($2.68).

The stock traded between $60.61 and $65.40 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 1.06 million shares, down versus the previous seven-day period, indicating lower trading activity.

PTCT 52-Week Price Position

Position in Range: 0.6%

52W Low$60.61

52W High$90.87

PTCT is currently trading at $60.79, placing it 0.6% of the way from its 52-week low of $60.61 to its 52-week high of $90.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is PTC Therapeutics, Inc. (PTCT)?

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

PTC Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	991
Exchange	NASDAQ
Company Website	https://www.ptcbio.com

How to Buy PTC Therapeutics, Inc. (PTCT) Stock on MEXC

Eligible investors can buy real shares of PTC Therapeutics, Inc. (PTCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PTCT and Place Your Order

Open the RealStocks trading page and search for PTCT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is PTC Therapeutics, Inc. (PTCT) stock price today?

PTC Therapeutics, Inc. (PTCT) is currently trading at $ 60.79, down 3.39% ($2.14) from the previous close of $ 62.92. Intraday prices update in real time during regular trading hours.

2.Is PTCT stock going up or down today?

As of 2026-10-13 15:04:53, PTCT is trading at $ 60.79, down 3.39% ($2.14) from its previous close of $ 62.92. The stock has traded between $ 4.03 and $ 90.87 during today’s regular session. Past price movements do not guarantee future results.

3.What is PTCT pre-market price?

As of 2026-10-13 15:04:53, PTCT is trading at $ 63.50 in pre-market trading, up 0.92% ($0.58) from the previous close of $ 62.92. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PTCT after-hours price?

As of 2026-10-13 15:04:53, PTCT is trading at $ 62.93 in after-hours trading, up 0.02% ($0.01) from the regular-session close of $ 62.92. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PTCT stock trading now?

PTCT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PTCT sit relative to its 52-week high and low?

Over the past 52 weeks, PTCT has traded between a low of $ 60.61 and a high of $ 90.87. At $ 60.79, the stock is positioned 0.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is PTC Therapeutics, Inc. in?

PTC Therapeutics, Inc. (PTCT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is PTC Therapeutics, Inc.'s market capitalisation and where is it listed?

PTC Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 5.40B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PTCT valued in terms of P/E ratio and EPS?

PTCT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.46. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does PTC Therapeutics, Inc. pay a dividend?

PTC Therapeutics, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.